Work

Increasing patient participation in oncology clinical trials

Year: 2022

Type: review

Abstract: AIM: Timely recruitment of eligible participants is essential for the success of clinical trials, with insufficient accrual being the leading cause for premature termination of both oncology and non-oncology trials. METHODS: In this paper we further elaborate on the challenges for patient participation in oncology trials from physician, patient, healthcare system, and some trial-related perspectives. RESULTS: We present strategies such as use of digital healthcare technologies, real-world data and real-world evidence, decentralized clinical trials, pragmatic trial designs, and supportive services to increase patient participation. CONCLUSIONS: Multifaceted measures are necessary to increase patient participation, especially for those who are under-represented in cancer trials.

Source: Cancer Medicine

DOI: 10.1002/cam4.5150

Authors: Jie Chen, Ying Lu, Shivaani Kummar

Institutions: Stanford Cancer Institute, Stanford University, Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: Ethics in Clinical Research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,700